Stryker, a prominent medtech corporation with a market cap of $131.6 billion, continues to execute a strategic acquisition spree by procuring Vertos Medical, a company pioneering minimally invasive procedures for lumbar spinal stenosis. The specifics of the financial arrangement and timeline for the acquisition remain undisclosed. Stryker’s President of Medsurg and Neurotechnology, Andy Pierce, emphasized the alignment of Vertos’s innovative treatments with Stryker’s mission to enhance patient quality of life through advanced pain management solutions. This acquisition is part of Stryker’s broader strategy to expand its minimally invasive pain management portfolio, as indicated by recent purchases including care.ai, Artelon, Molli Surgical, Serf SAS, and mfPHD. These acquisitions underscore Stryker CEO Kevin Lobo’s forecast of a dynamic M&A landscape for the remainder of the year, with a robust pipeline of deals.
Medical Technology, Healthcare,United States
https://mergersacquisitions.einnews.com/article/737571181/OPHvR48tzkHD8znT?ref=rss&ecode=Q1vNcweEggLWKz7L